Insider · CIK 0002088590
Thomas Martin Kuendig
Files at XBIT (XBiotech Inc.). First filing -, latest -.
In brief
Thomas Martin Kuendig files SEC Form 4 as director at XBIT (XBiotech Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Thomas Martin Kuendig has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | XBIT XBiotech Inc. | AGrant or award Director Stock Optionderivative | +79,115 | $0.00 | $0 | 79,115 | Nov 12, 2025 |
Questions about Thomas Martin Kuendig
Answered from the filings on this page, as of the latest one.
Is Thomas Martin Kuendig buying or selling?
Thomas Martin Kuendig has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Thomas Martin Kuendig's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas Martin Kuendig has 0.
Where does Thomas Martin Kuendig file Form 4?
Thomas Martin Kuendig has filed Form 4 at XBIT (XBiotech Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.